Most of the focus in Washington on AI centers on how agencies should regulate its use by the private sector, with the FDA planning rules for its use in health care.
Related posts:
Recall or science? Newsom’s sudden reopening push has many wondering
Opioid lawsuits on verge of settlements with 4 companies
NFL: Covid outbreaks among unvaccinated players could mean forfeits
CDC sets shorter Covid isolation rules for health workers
Thousands line up for ‘jingle jabs’ on Christmas in England
CDC plans to cut recommended quarantine time amid Omicron surge
U.S. sets new daily high for Covid cases
Trump plan favored giving vaccines to Israel, Taiwan over poorer countries
‘The White House isn’t supporting him’: Biden’s FDA pick left in limbo
Beijing seals off more residential areas over Covid
Monkeypox may be here to stay
Fauci: ‘We are not where we need to be if we are going to quote ‘live with the virus”
